Articles:

Overview: NCI Workshop on Investigational Strategies for Detection and Intervention in Early Lung Cancer

James L. Mulshine
Cancer Res 1992 52: 2639s-2640s. [PDF]  

Methods and Strategies in Lung Cancer Control

Andre Castonguay
Cancer Res 1992 52: 2641s-2651s. [Abstract] [PDF]  

New Approaches to Treating Early Lung Cancer

Jack A. Roth
Cancer Res 1992 52: 2652s-2657s. [Abstract] [PDF]  

Application of Molecular Genetics to the Early Diagnosis and Screening of Lung Cancer

Michael J. Birrer and Powel H. Brown
Cancer Res 1992 52: 2658s-2664s. [Abstract] [PDF]  

Clinical Significance of ras Oncogene Activation in Human Lung Cancer

Sjoerd Rodenhuis and Robert J. C. Slebos
Cancer Res 1992 52: 2665s-2669s. [Abstract] [PDF]  

Primary Lung Tumors in Mice: An Experimentally Manipulable Model of Human Adenocarcinoma

Alvin M. Malkinson
Cancer Res 1992 52: 2670s-2676s. [Abstract] [PDF]  

Induction and Spontaneous Regression of Intense Pulmonary Neuroendocrine Cell Differentiation in a Model of Preneoplastic Lung Injury

Mary E. Sunday and Christopher G. Willett
Cancer Res 1992 52: 2677s-2686s. [Abstract] [PDF]  

Bronchial and Pulmonary Carcinogenesis at Focal Sites in Dogs and Hamsters

John R. Benfield and William G. Hammond
Cancer Res 1992 52: 2687s-2693s. [Abstract] [PDF]  

Lung Cancer Detection and Prevention: Evidence for an Interaction between Smoking and Genetic Predisposition

Thomas A. Sellers, John D. Potter, Joan E. Bailey-Wilson, Stephen S. Rich, Henry Rothschild, and Robert C. Elston
Cancer Res 1992 52: 2694s-2697s. [Abstract] [PDF]  

DNA and Hemoglobin Adducts as Markers of Metabolic Activation of Tobacco-specific Carcinogens

Peter G. Foiles, Sharon E. Murphy, Lisa A. Peterson, Steven G. Carmella, and Stephen S. Hecht
Cancer Res 1992 52: 2698s-2701s. [Abstract] [PDF]  

Chromosome Abnormalities in Human Non-Small Cell Lung Cancer

Joseph R. Testa and Jill M. Siegfried
Cancer Res 1992 52: 2702s-2706s. [Abstract] [PDF]  

Determination of Biomarkers for Intermediate End Points in Chemoprevention Trials

Jin S. Lee, Scott M. Lippman, Waun K. Hong, Jae Y. Ro, Sun Y. Kim, Reuben Lotan, and Walter N. Hittelman
Cancer Res 1992 52: 2707s-2710s. [Abstract] [PDF]  

Considerations in Bringing a Cancer Biomarker to Clinical Application

Melvyn S. Tockman, Prabodh K. Gupta, Norman J. Pressman, and James L. Mulshine
Cancer Res 1992 52: 2711s-2718s. [Abstract] [PDF]  

New Potential Chemopreventive Agents for Lung Carcinogenesis of Tobacco-specific Nitrosamine

Fung-Lung Chung, Mark A. Morse, and Karin I. Eklind
Cancer Res 1992 52: 2719s-2722s. [Abstract] [PDF]  

Nitrosamine-induced Lung Carcinogenesis and Ca²⁺/Calmodulin Antagonists

Hildegard M. Schüller
Cancer Res 1992 52: 2723s-2726s. [Abstract] [PDF]  

Urinary Levels of Bombesin-like Peptides in Asymptomatic Cigarette Smokers: A Potential Risk Marker for Smoking-related Diseases

Samuel M. Aguayo, Talmadge E. King, Jr., Madeleine A. Kane, Karen M. Sherritt, Wayne Silvers, Louise M. Nett, Thomas L. Petty, and York E. Miller
Cancer Res 1992 52: 2727s-2731s. [Abstract] [PDF]  

Neuromedin B Is Present in Lung Cancer Cell Lines

G. Giaccone, J. Battey, A. F. Gazdar, H. Oie, M. Draoui, and T. W. Moody
Cancer Res 1992 52: 2732s-2736s. [Abstract] [PDF]  

Growth of Small Cell Lung Cancer Cells: Stimulation by Multiple Neuropeptides and Inhibition by Broad Spectrum Antagonists in Vitro and in Vivo

Tariq Sethi, Simon Langdon, John Smyth, and Enrique Rozengurt
Cancer Res 1992 52: 2737s-2742s. [Abstract] [PDF]  

The Correct Dose: Pharmacologically Guided End Point for Anti-Growth Factor Therapy

James L. Mulshine, Noriyuki Shuke, Farhad Daghighian, Jorge Carrasquillo, Bimal Ghosh, Thomas Walsh, Ingalill Avis, James C. Reynolds, Frank Cuttitta, and Steven M. Larson
Cancer Res 1992 52: 2743s-2746s. [Abstract] [PDF]  

Early Intervention in Cancer Using Monoclonal Antibodies and Other Biological Ligands: Micropharmacology and the "Binding Site Barrier"

John N. Weinstein and William van Osdol
Cancer Res 1992 52: 2747s-2751s. [Abstract] [PDF]  

The Clinical Evaluation of Cancer Chemoprevention Agents: Defining and Contrasting Phase I, II, and III Objectives

Gary E. Goodman
Cancer Res 1992 52: 2752s-2757s. [Abstract] [PDF]  

Chemoprevention Strategies for Lung and Upper Aerodigestive Tract Cancer

Steven E. Benner, Scott M. Lippman, and Waun Ki Hong
Cancer Res 1992 52: 2758s-2763s. [Abstract] [PDF]  

Preclinical Research in Early Lung Cancer: Breakout Group Report

M. Mabry, T. W. Moody, and S. B. Baylin
Cancer Res 1992 52: 2764s-2765s. [PDF]  

Diagnostic Research: Breakout Group Report

James L. Mulshine and Melvyn S. Tockman
Cancer Res 1992 52: 2766s [PDF]  

Intervention Approaches in Early Lung Cancer and Premalignant Disease: Breakout Group Report

Daniel C. Ihde and Scott Lippman
Cancer Res 1992 52: 2767s-2768s. [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.